SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950142-19-001097
Filing Date
2019-05-15
Accepted
2019-05-15 14:45:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G es1900671_13g-milestone.htm SC 13G 63477
  Complete submission text file 0000950142-19-001097.txt   65009
Mailing Address 545 CREMAZIE BLVD. EAST, SUITE 200 MONTREAL A8 H2M 2W4
Business Address 545 CREMAZIE BLVD. EAST, SUITE 200 MONTREAL A8 H2M 2W4 514-383-8383
FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC (Filed by) CIK: 0000903337 (see all company filings)

IRS No.: 980140536 | State of Incorp.: XX | Fiscal Year End: 0630
Type: SC 13G

Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Subject) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8
Type: SC 13G | Act: 34 | File No.: 005-91001 | Film No.: 19827249
SIC: 2834 Pharmaceutical Preparations